Investors are optimistic about Exact Sciences (EXAS) on continued strength across the Screening and Precision Oncology businesses.
Shares of Exact Sciences, Inc. EXAS have been on a tear, having gained over 27% in two sessions this week.
Exact Science's stock price is shooting higher this week amid posting upward revisions for its revenue and earnings estimates for this quarter.

Strength Seen in Exact Sciences (EXAS): Can Its 24.7% Jump Turn into More Strength?

02:55pm, Tuesday, 10'th Jan 2023 Zacks Investment Research
Exact Sciences (EXAS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price incre

Is Bionano Genomics (BNGO) Stock Outpacing Its Medical Peers This Year?

02:40pm, Tuesday, 10'th Jan 2023 Zacks Investment Research
Here is how Bionano Genomics, Inc. (BNGO) and Exact Sciences (EXAS) have performed compared to their sector so far this year.
As we head into a new year, investors are taking a look at their portfolios to determine which stocks were winners and losers in 2022.
Exact Sciences Corp (NASDAQ: EXAS) gapped up more than 16% to start the trading day on Monday and continued to surge an additional 5.6% before hitting and rejecting a resistance area near $58.50. The
Gainers CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash. Apexigen, Inc. (NASDAQ: APGN) jumped 111% to
U.S. stocks traded higher, with the Dow Jones gaining more than 150 points on Monday. Here are some big stocks recording losses in today’s session. CinCor Pharma, Inc. (NASDAQ: CINC) shares surged
Exact Sciences Corp EXAS gapped up more than 16% to start the trading day on Monday and continued to surge an additional 5.6% before hitting and rejecting a resistance area near $58.50.
EXAS stock jumped as the provider of cancer screening and diagnostic tests raised estimates for its fourth quarter. The post Exact Sciences Raises Fourth-Quarter Estimates Above Expectations appeared
Exact Sciences Corp EXAS shares are trading higher Monday after the company announced preliminary fourth-quarter results.
ARK Invest's Cathie Wood believes Exact Sciences (EXAS) can hit $140 per share by 2027. Unlike some other calls, I believe Cathie and ARK are spot-on with EXAS. EXAS is a major holding in both Cathie'

Tesla: Woke Mob Fury - 20 Top Growth Stocks Ranked

12:07pm, Saturday, 07'th Jan 2023 Seeking Alpha
Tesla shares are down 70%, despite the fact that revenues and profits keep growing rapidly. Read more to see why TSLA is a Buy for long-term growth investors.

Investing in Tech ETFs

05:24pm, Friday, 06'th Jan 2023 The Motley Fool
Here's how to get tech exposure without the single-stock risk.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE